Enlarged Merck & Co keen to sign biotech deals
This article was originally published in Scrip
Executive Summary
Merck & Co will be increasing its partnering and licensing activity "to feed the bigger beast" resulting from the acquisition of Schering-Plough, its head of licensing and external research Dr Margaret Beer told yesterday's BioFinance and BioInnovate Europe meeting in London.